Resonance Health Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was AUD 3.83 million compared to AUD 3.78 million a year ago. Net loss was AUD 1.14 million compared to net income of AUD 0.585858 million a year ago.

Basic loss per share from continuing operations was AUD 0.0025 compared to basic earnings per share from continuing operations of AUD 0.0013 a year ago. Diluted loss per share from continuing operations was AUD 0.0025 compared to diluted earnings per share from continuing operations of AUD 0.0013 a year ago.